Global Intranasal Drug and Vaccine Delivery Devices Market Research Report 2023
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intranasal Drug and Vaccine Delivery Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
By Company
- Teva Pharmaceuticals
- GlaxoSmithKline
- Teleflex
- Intersect
- Aptar Pharma
- 3M
- OptiNose
- UCB
- Bespak
- Powder Conveyor
- Liquid Delivery Device
- Pressurized Metered Dose Inhaler
- Other
- Respiratory Diseases
- Nervous System Disease
- Vaccination
- Pain Department
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET OVERVIEW
1.1 Product Overview and Scope of Intranasal Drug and Vaccine Delivery Devices
1.2 Intranasal Drug and Vaccine Delivery Devices Segment by Type
1.2.1 Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Type (2023-2029)
1.2.2 Powder Conveyor
1.2.3 Liquid Delivery Device
1.2.4 Pressurized Metered Dose Inhaler
1.2.5 Other
1.3 Intranasal Drug and Vaccine Delivery Devices Segment by Application
1.3.1 Global Intranasal Drug and Vaccine Delivery Devices Market Value by Application: (2023-2029)
1.3.2 Respiratory Diseases
1.3.3 Nervous System Disease
1.3.4 Vaccination
1.3.5 Pain Department
1.3.6 Other
1.4 Global Intranasal Drug and Vaccine Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue 2018-2029
1.4.2 Global Intranasal Drug and Vaccine Delivery Devices Sales 2018-2029
1.4.3 Global Intranasal Drug and Vaccine Delivery Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET COMPETITION BY MANUFACTURERS
2.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturers (2018-2023)
2.4 Global Intranasal Drug and Vaccine Delivery Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Product Type & Application
2.7 Intranasal Drug and Vaccine Delivery Devices Market Competitive Situation and Trends
2.7.1 Intranasal Drug and Vaccine Delivery Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intranasal Drug and Vaccine Delivery Devices Players Market Share by Revenue
2.7.3 Global Intranasal Drug and Vaccine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intranasal Drug and Vaccine Delivery Devices Global Intranasal Drug and Vaccine Delivery Devices Sales by Region: 2018-2029
3.2.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Region: 2018-2023
3.2.2 Global Intranasal Drug and Vaccine Delivery Devices Sales by Region: 2024-2029
3.3 Global Intranasal Drug and Vaccine Delivery Devices Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2018-2029
3.3.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2018-2023
3.3.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2024-2029
3.4 North America Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.4.1 North America Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2029)
3.4.3 North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2029)
3.5.3 Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2029)
3.7.3 Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Type (2018-2029)
4.1.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Type (2018-2023)
4.1.2 Global Intranasal Drug and Vaccine Delivery Devices Sales by Type (2024-2029)
4.1.3 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2018-2029)
4.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Type (2018-2029)
4.2.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Type (2018-2023)
4.2.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Type (2024-2029)
4.2.3 Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Type (2018-2029)
4.3 Global Intranasal Drug and Vaccine Delivery Devices Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2018-2029)
5.1.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2018-2023)
5.1.2 Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2024-2029)
5.1.3 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2018-2029)
5.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Application (2018-2029)
5.2.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Application (2018-2023)
5.2.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Application (2024-2029)
5.2.3 Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Application (2018-2029)
5.3 Global Intranasal Drug and Vaccine Delivery Devices Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Teva Pharmaceuticals
6.1.1 Teva Pharmaceuticals Corporation Information
6.1.2 Teva Pharmaceuticals Description and Business Overview
6.1.3 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.1.5 Teva Pharmaceuticals Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Teleflex
6.3.1 Teleflex Corporation Information
6.3.2 Teleflex Description and Business Overview
6.3.3 Teleflex Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teleflex Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.3.5 Teleflex Recent Developments/Updates
6.4 Intersect
6.4.1 Intersect Corporation Information
6.4.2 Intersect Description and Business Overview
6.4.3 Intersect Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Intersect Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.4.5 Intersect Recent Developments/Updates
6.5 Aptar Pharma
6.5.1 Aptar Pharma Corporation Information
6.5.2 Aptar Pharma Description and Business Overview
6.5.3 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.5.5 Aptar Pharma Recent Developments/Updates
6.6 3M
6.6.1 3M Corporation Information
6.6.2 3M Description and Business Overview
6.6.3 3M Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 3M Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 OptiNose
6.6.1 OptiNose Corporation Information
6.6.2 OptiNose Description and Business Overview
6.6.3 OptiNose Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 OptiNose Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.7.5 OptiNose Recent Developments/Updates
6.8 UCB
6.8.1 UCB Corporation Information
6.8.2 UCB Description and Business Overview
6.8.3 UCB Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 UCB Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.8.5 UCB Recent Developments/Updates
6.9 Bespak
6.9.1 Bespak Corporation Information
6.9.2 Bespak Description and Business Overview
6.9.3 Bespak Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bespak Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.9.5 Bespak Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Intranasal Drug and Vaccine Delivery Devices Industry Chain Analysis
7.2 Intranasal Drug and Vaccine Delivery Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intranasal Drug and Vaccine Delivery Devices Production Mode & Process
7.4 Intranasal Drug and Vaccine Delivery Devices Sales and Marketing
7.4.1 Intranasal Drug and Vaccine Delivery Devices Sales Channels
7.4.2 Intranasal Drug and Vaccine Delivery Devices Distributors
7.5 Intranasal Drug and Vaccine Delivery Devices Customers
8 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET DYNAMICS
8.1 Intranasal Drug and Vaccine Delivery Devices Industry Trends
8.2 Intranasal Drug and Vaccine Delivery Devices Market Drivers
8.3 Intranasal Drug and Vaccine Delivery Devices Market Challenges
8.4 Intranasal Drug and Vaccine Delivery Devices Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Intranasal Drug and Vaccine Delivery Devices
1.2 Intranasal Drug and Vaccine Delivery Devices Segment by Type
1.2.1 Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Type (2023-2029)
1.2.2 Powder Conveyor
1.2.3 Liquid Delivery Device
1.2.4 Pressurized Metered Dose Inhaler
1.2.5 Other
1.3 Intranasal Drug and Vaccine Delivery Devices Segment by Application
1.3.1 Global Intranasal Drug and Vaccine Delivery Devices Market Value by Application: (2023-2029)
1.3.2 Respiratory Diseases
1.3.3 Nervous System Disease
1.3.4 Vaccination
1.3.5 Pain Department
1.3.6 Other
1.4 Global Intranasal Drug and Vaccine Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue 2018-2029
1.4.2 Global Intranasal Drug and Vaccine Delivery Devices Sales 2018-2029
1.4.3 Global Intranasal Drug and Vaccine Delivery Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET COMPETITION BY MANUFACTURERS
2.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturers (2018-2023)
2.4 Global Intranasal Drug and Vaccine Delivery Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Product Type & Application
2.7 Intranasal Drug and Vaccine Delivery Devices Market Competitive Situation and Trends
2.7.1 Intranasal Drug and Vaccine Delivery Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intranasal Drug and Vaccine Delivery Devices Players Market Share by Revenue
2.7.3 Global Intranasal Drug and Vaccine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intranasal Drug and Vaccine Delivery Devices Global Intranasal Drug and Vaccine Delivery Devices Sales by Region: 2018-2029
3.2.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Region: 2018-2023
3.2.2 Global Intranasal Drug and Vaccine Delivery Devices Sales by Region: 2024-2029
3.3 Global Intranasal Drug and Vaccine Delivery Devices Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2018-2029
3.3.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2018-2023
3.3.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2024-2029
3.4 North America Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.4.1 North America Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2029)
3.4.3 North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2029)
3.5.3 Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2029)
3.7.3 Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Type (2018-2029)
4.1.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Type (2018-2023)
4.1.2 Global Intranasal Drug and Vaccine Delivery Devices Sales by Type (2024-2029)
4.1.3 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2018-2029)
4.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Type (2018-2029)
4.2.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Type (2018-2023)
4.2.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Type (2024-2029)
4.2.3 Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Type (2018-2029)
4.3 Global Intranasal Drug and Vaccine Delivery Devices Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2018-2029)
5.1.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2018-2023)
5.1.2 Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2024-2029)
5.1.3 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2018-2029)
5.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Application (2018-2029)
5.2.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Application (2018-2023)
5.2.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Application (2024-2029)
5.2.3 Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Application (2018-2029)
5.3 Global Intranasal Drug and Vaccine Delivery Devices Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Teva Pharmaceuticals
6.1.1 Teva Pharmaceuticals Corporation Information
6.1.2 Teva Pharmaceuticals Description and Business Overview
6.1.3 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.1.5 Teva Pharmaceuticals Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Teleflex
6.3.1 Teleflex Corporation Information
6.3.2 Teleflex Description and Business Overview
6.3.3 Teleflex Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teleflex Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.3.5 Teleflex Recent Developments/Updates
6.4 Intersect
6.4.1 Intersect Corporation Information
6.4.2 Intersect Description and Business Overview
6.4.3 Intersect Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Intersect Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.4.5 Intersect Recent Developments/Updates
6.5 Aptar Pharma
6.5.1 Aptar Pharma Corporation Information
6.5.2 Aptar Pharma Description and Business Overview
6.5.3 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.5.5 Aptar Pharma Recent Developments/Updates
6.6 3M
6.6.1 3M Corporation Information
6.6.2 3M Description and Business Overview
6.6.3 3M Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 3M Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 OptiNose
6.6.1 OptiNose Corporation Information
6.6.2 OptiNose Description and Business Overview
6.6.3 OptiNose Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 OptiNose Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.7.5 OptiNose Recent Developments/Updates
6.8 UCB
6.8.1 UCB Corporation Information
6.8.2 UCB Description and Business Overview
6.8.3 UCB Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 UCB Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.8.5 UCB Recent Developments/Updates
6.9 Bespak
6.9.1 Bespak Corporation Information
6.9.2 Bespak Description and Business Overview
6.9.3 Bespak Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bespak Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.9.5 Bespak Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Intranasal Drug and Vaccine Delivery Devices Industry Chain Analysis
7.2 Intranasal Drug and Vaccine Delivery Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intranasal Drug and Vaccine Delivery Devices Production Mode & Process
7.4 Intranasal Drug and Vaccine Delivery Devices Sales and Marketing
7.4.1 Intranasal Drug and Vaccine Delivery Devices Sales Channels
7.4.2 Intranasal Drug and Vaccine Delivery Devices Distributors
7.5 Intranasal Drug and Vaccine Delivery Devices Customers
8 INTRANASAL DRUG AND VACCINE DELIVERY DEVICES MARKET DYNAMICS
8.1 Intranasal Drug and Vaccine Delivery Devices Industry Trends
8.2 Intranasal Drug and Vaccine Delivery Devices Market Drivers
8.3 Intranasal Drug and Vaccine Delivery Devices Market Challenges
8.4 Intranasal Drug and Vaccine Delivery Devices Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Intranasal Drug and Vaccine Delivery Devices Market Competitive Situation by Manufacturers in 2022
Table 4. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Intranasal Drug and Vaccine Delivery Devices Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Intranasal Drug and Vaccine Delivery Devices Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Intranasal Drug and Vaccine Delivery Devices, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Product Type & Application
Table 12. Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intranasal Drug and Vaccine Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug and Vaccine Delivery Devices as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Intranasal Drug and Vaccine Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 18. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2018-2023)
Table 19. Global Intranasal Drug and Vaccine Delivery Devices Sales by Region (2024-2029) & (K Units)
Table 20. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2024-2029)
Table 21. Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Region (2018-2023)
Table 23. Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Region (2024-2029)
Table 25. North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 27. North America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 28. North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 32. Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 33. Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Type (2018-2023)
Table 51. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Type (2024-2029)
Table 52. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2018-2023)
Table 53. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2024-2029)
Table 54. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Type (2018-2023)
Table 57. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Type (2024-2029)
Table 58. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Type (2018-2023)
Table 59. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Type (2024-2029)
Table 60. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Application (2018-2023)
Table 61. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Application (2024-2029)
Table 62. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2018-2023)
Table 63. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2024-2029)
Table 64. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Application (2018-2023)
Table 67. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Application (2024-2029)
Table 68. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Application (2018-2023)
Table 69. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Application (2024-2029)
Table 70. Teva Pharmaceuticals Corporation Information
Table 71. Teva Pharmaceuticals Description and Business Overview
Table 72. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product
Table 74. Teva Pharmaceuticals Recent Developments/Updates
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product
Table 79. GlaxoSmithKline Recent Developments/Updates
Table 80. Teleflex Corporation Information
Table 81. Teleflex Description and Business Overview
Table 82. Teleflex Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Teleflex Intranasal Drug and Vaccine Delivery Devices Product
Table 84. Teleflex Recent Developments/Updates
Table 85. Intersect Corporation Information
Table 86. Intersect Description and Business Overview
Table 87. Intersect Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Intersect Intranasal Drug and Vaccine Delivery Devices Product
Table 89. Intersect Recent Developments/Updates
Table 90. Aptar Pharma Corporation Information
Table 91. Aptar Pharma Description and Business Overview
Table 92. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product
Table 94. Aptar Pharma Recent Developments/Updates
Table 95. 3M Corporation Information
Table 96. 3M Description and Business Overview
Table 97. 3M Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. 3M Intranasal Drug and Vaccine Delivery Devices Product
Table 99. 3M Recent Developments/Updates
Table 100. OptiNose Corporation Information
Table 101. OptiNose Description and Business Overview
Table 102. OptiNose Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. OptiNose Intranasal Drug and Vaccine Delivery Devices Product
Table 104. OptiNose Recent Developments/Updates
Table 105. UCB Corporation Information
Table 106. UCB Description and Business Overview
Table 107. UCB Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. UCB Intranasal Drug and Vaccine Delivery Devices Product
Table 109. UCB Recent Developments/Updates
Table 110. Bespak Corporation Information
Table 111. Bespak Description and Business Overview
Table 112. Bespak Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Bespak Intranasal Drug and Vaccine Delivery Devices Product
Table 114. Bespak Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Intranasal Drug and Vaccine Delivery Devices Distributors List
Table 118. Intranasal Drug and Vaccine Delivery Devices Customers List
Table 119. Intranasal Drug and Vaccine Delivery Devices Market Trends
Table 120. Intranasal Drug and Vaccine Delivery Devices Market Drivers
Table 121. Intranasal Drug and Vaccine Delivery Devices Market Challenges
Table 122. Intranasal Drug and Vaccine Delivery Devices Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 1. Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Intranasal Drug and Vaccine Delivery Devices Market Competitive Situation by Manufacturers in 2022
Table 4. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Intranasal Drug and Vaccine Delivery Devices Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Intranasal Drug and Vaccine Delivery Devices Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Intranasal Drug and Vaccine Delivery Devices, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Product Type & Application
Table 12. Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intranasal Drug and Vaccine Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug and Vaccine Delivery Devices as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Intranasal Drug and Vaccine Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 18. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2018-2023)
Table 19. Global Intranasal Drug and Vaccine Delivery Devices Sales by Region (2024-2029) & (K Units)
Table 20. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2024-2029)
Table 21. Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Region (2018-2023)
Table 23. Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Region (2024-2029)
Table 25. North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 27. North America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 28. North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 32. Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 33. Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Type (2018-2023)
Table 51. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Type (2024-2029)
Table 52. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2018-2023)
Table 53. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2024-2029)
Table 54. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Type (2018-2023)
Table 57. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Type (2024-2029)
Table 58. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Type (2018-2023)
Table 59. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Type (2024-2029)
Table 60. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Application (2018-2023)
Table 61. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Application (2024-2029)
Table 62. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2018-2023)
Table 63. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2024-2029)
Table 64. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Application (2018-2023)
Table 67. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Application (2024-2029)
Table 68. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Application (2018-2023)
Table 69. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Application (2024-2029)
Table 70. Teva Pharmaceuticals Corporation Information
Table 71. Teva Pharmaceuticals Description and Business Overview
Table 72. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product
Table 74. Teva Pharmaceuticals Recent Developments/Updates
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product
Table 79. GlaxoSmithKline Recent Developments/Updates
Table 80. Teleflex Corporation Information
Table 81. Teleflex Description and Business Overview
Table 82. Teleflex Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Teleflex Intranasal Drug and Vaccine Delivery Devices Product
Table 84. Teleflex Recent Developments/Updates
Table 85. Intersect Corporation Information
Table 86. Intersect Description and Business Overview
Table 87. Intersect Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Intersect Intranasal Drug and Vaccine Delivery Devices Product
Table 89. Intersect Recent Developments/Updates
Table 90. Aptar Pharma Corporation Information
Table 91. Aptar Pharma Description and Business Overview
Table 92. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product
Table 94. Aptar Pharma Recent Developments/Updates
Table 95. 3M Corporation Information
Table 96. 3M Description and Business Overview
Table 97. 3M Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. 3M Intranasal Drug and Vaccine Delivery Devices Product
Table 99. 3M Recent Developments/Updates
Table 100. OptiNose Corporation Information
Table 101. OptiNose Description and Business Overview
Table 102. OptiNose Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. OptiNose Intranasal Drug and Vaccine Delivery Devices Product
Table 104. OptiNose Recent Developments/Updates
Table 105. UCB Corporation Information
Table 106. UCB Description and Business Overview
Table 107. UCB Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. UCB Intranasal Drug and Vaccine Delivery Devices Product
Table 109. UCB Recent Developments/Updates
Table 110. Bespak Corporation Information
Table 111. Bespak Description and Business Overview
Table 112. Bespak Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Bespak Intranasal Drug and Vaccine Delivery Devices Product
Table 114. Bespak Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Intranasal Drug and Vaccine Delivery Devices Distributors List
Table 118. Intranasal Drug and Vaccine Delivery Devices Customers List
Table 119. Intranasal Drug and Vaccine Delivery Devices Market Trends
Table 120. Intranasal Drug and Vaccine Delivery Devices Market Drivers
Table 121. Intranasal Drug and Vaccine Delivery Devices Market Challenges
Table 122. Intranasal Drug and Vaccine Delivery Devices Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Intranasal Drug and Vaccine Delivery Devices
Figure 2. Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Type in 2022 & 2029
Figure 4. Powder Conveyor Product Picture
Figure 5. Liquid Delivery Device Product Picture
Figure 6. Pressurized Metered Dose Inhaler Product Picture
Figure 7. Other Product Picture
Figure 8. Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Application in 2022 & 2029
Figure 10. Respiratory Diseases
Figure 11. Nervous System Disease
Figure 12. Vaccination
Figure 13. Pain Department
Figure 14. Other
Figure 15. Global Intranasal Drug and Vaccine Delivery Devices Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Intranasal Drug and Vaccine Delivery Devices Market Size (2018-2029) & (US$ Million)
Figure 17. Global Intranasal Drug and Vaccine Delivery Devices Sales (2018-2029) & (K Units)
Figure 18. Global Intranasal Drug and Vaccine Delivery Devices Average Price (US$/Unit) & (2018-2029)
Figure 19. Intranasal Drug and Vaccine Delivery Devices Report Years Considered
Figure 20. Intranasal Drug and Vaccine Delivery Devices Sales Share by Manufacturers in 2022
Figure 21. Global Intranasal Drug and Vaccine Delivery Devices Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Intranasal Drug and Vaccine Delivery Devices Players: Market Share by Revenue in 2022
Figure 23. Intranasal Drug and Vaccine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2018-2029)
Figure 26. North America Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 27. United States Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2018-2029)
Figure 30. Europe Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 31. Germany Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Region (2018-2029)
Figure 38. China Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2018-2029)
Figure 46. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Colombia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Intranasal Drug and Vaccine Delivery Devices by Type (2018-2029)
Figure 57. Global Revenue Market Share of Intranasal Drug and Vaccine Delivery Devices by Type (2018-2029)
Figure 58. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Intranasal Drug and Vaccine Delivery Devices by Application (2018-2029)
Figure 60. Global Revenue Market Share of Intranasal Drug and Vaccine Delivery Devices by Application (2018-2029)
Figure 61. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Application (2018-2029)
Figure 62. Intranasal Drug and Vaccine Delivery Devices Value Chain
Figure 63. Intranasal Drug and Vaccine Delivery Devices Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Product Picture of Intranasal Drug and Vaccine Delivery Devices
Figure 2. Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Type in 2022 & 2029
Figure 4. Powder Conveyor Product Picture
Figure 5. Liquid Delivery Device Product Picture
Figure 6. Pressurized Metered Dose Inhaler Product Picture
Figure 7. Other Product Picture
Figure 8. Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Application in 2022 & 2029
Figure 10. Respiratory Diseases
Figure 11. Nervous System Disease
Figure 12. Vaccination
Figure 13. Pain Department
Figure 14. Other
Figure 15. Global Intranasal Drug and Vaccine Delivery Devices Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Intranasal Drug and Vaccine Delivery Devices Market Size (2018-2029) & (US$ Million)
Figure 17. Global Intranasal Drug and Vaccine Delivery Devices Sales (2018-2029) & (K Units)
Figure 18. Global Intranasal Drug and Vaccine Delivery Devices Average Price (US$/Unit) & (2018-2029)
Figure 19. Intranasal Drug and Vaccine Delivery Devices Report Years Considered
Figure 20. Intranasal Drug and Vaccine Delivery Devices Sales Share by Manufacturers in 2022
Figure 21. Global Intranasal Drug and Vaccine Delivery Devices Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Intranasal Drug and Vaccine Delivery Devices Players: Market Share by Revenue in 2022
Figure 23. Intranasal Drug and Vaccine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2018-2029)
Figure 26. North America Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 27. United States Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2018-2029)
Figure 30. Europe Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 31. Germany Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Region (2018-2029)
Figure 38. China Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2018-2029)
Figure 46. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Colombia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Intranasal Drug and Vaccine Delivery Devices by Type (2018-2029)
Figure 57. Global Revenue Market Share of Intranasal Drug and Vaccine Delivery Devices by Type (2018-2029)
Figure 58. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Intranasal Drug and Vaccine Delivery Devices by Application (2018-2029)
Figure 60. Global Revenue Market Share of Intranasal Drug and Vaccine Delivery Devices by Application (2018-2029)
Figure 61. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Application (2018-2029)
Figure 62. Intranasal Drug and Vaccine Delivery Devices Value Chain
Figure 63. Intranasal Drug and Vaccine Delivery Devices Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
